Advertisement

Is Mortality in Patients with Atrial Fibrillation Related to the Underlying Heart Disease or to the Arrhythmia?

  • F. Di Pede
  • G. Zuin
Conference paper

Abstract

Atrial fibrillation (AF) is considered one of the most common clinically relevant cardiac arrhythmias. The prevalence of AF increases with age and is reported to be 0.2%–0.3% at age 25 – 35 years, 3%–4% at age 55 – 64 years, and 5%–9% at age 62 – 90 years (1). AF is usually a consequence of heart disease involving the left atrium, but may also result from extracardiac conditions such as hyperthyroidism, surgery, acute alcohol intoxication, cholinergic drug use, or diagnostic procedures. In a minority of patients, no contributing factors or overt heart disease can be identified (lone AF). In most cases the clinical and hemodynamic consequences of AF are related to the severity of underlying heart disease.

Keywords

Atrial Fibrillation Pulmonary Capillary Wedge Pressure Stroke Prevention Chronic Atrial Fibrillation Underlying Heart Disease 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Kannel WB, Wolf PA (1992) Epidemiology of atrial fibrillation. In: Falk RH, Podrid PJ (eds) Atrial fibrillation. Mechanisms and management. Raven, New York, pp 81–92Google Scholar
  2. 2.
    Ruskin J, McHale PA, Harley A, Greenfield JC Jr (1970) Pressure-flow studies in man: effects of atrial systole on left ventricular function. J Clin Invest 49: 472–478PubMedCrossRefGoogle Scholar
  3. 3.
    Atwood JE (1992) Exercise hemodynamics of atrial fibrillation. In: Falk RH, Podrid PJ (eds) Atrial fibrillation. Mechanism and management. Raven, New York, pp 145–163Google Scholar
  4. 4.
    Rahimtoola SH, Ehsani A, Sinno MZ et al (1975) Left atrial transport function in myocardial infarction: importance of its booster function. Am J Med 59: 686–693PubMedCrossRefGoogle Scholar
  5. 5.
    Greenberg B, Chatterjee K, Parmley WW, Werner JA, Holly AN (1980) The influence of left ventricular filling pressure on atrial contribution to cardiac output. Am Heart J 98: 742751Google Scholar
  6. 6.
    Pehrsson SK (1983) Influence of heart rate and atrioventricular synchronization on maximal work tolerance in patients treated with artificial pacemaker. Acta Med Scand 214: 311–315PubMedCrossRefGoogle Scholar
  7. 7.
    Ausubel K, Steingart RM, Shimshi M, Klementowicz P, Furman S (1985) Maintenance of exercise stroke volume during ventricular versus atrial synchronous pacing: role of contractility. Circulation 72: 1037PubMedCrossRefGoogle Scholar
  8. 8.
    Fananapazir L, Bennet DH, Monks P (1983) Atrial synchronized ventricular pacing: contribution of the chronotropic response to improved exercise performance. Pace 6: 601–605PubMedCrossRefGoogle Scholar
  9. 9.
    Fananapazir L, Srinivas V, Bennet DH (1983) Comparison of resting hemodynamic indices and exercise performance during atrial synchronized and asynchronous ventricular pacing. Pace 6: 202–206PubMedCrossRefGoogle Scholar
  10. 10.
    Naito M, David D, Michelson EL, Schaffenburg M, Dreifus LS (1983) The hemodynamic consequences of cardiac arrhythmias: evaluation of the relative roles of abnormal atrioventricular sequencing, irregularity of ventricular rhythm and atrial fibrillation in a canine model. Am Heart J 106: 284–291PubMedCrossRefGoogle Scholar
  11. 11.
    Piccolo E, Di Pede F, Millosevich P (1993) Ablazione transcatetere della giunzione AV ed impianto di Pace-Maker in pazienti con fibrillazione e flutter atriale: la regolarizzazione dei cicli ventricolari migliora la funzione cardiaca? In: Piccolo E, Raviele A (eds) Third International Workshop on Cardiac Arrythmias, Venice, 21–23 October 1993. Centro Scientifico Editore, Torino, pp 79–92Google Scholar
  12. 12.
    Packer DL, Bardy GH, Worley SJ, Smith MS, Cobb FR, Coleman E, Gallagher JJ, German LD (1986) Tachycardia-induced cardiomyopathy: a reversible form of left ventricular dysfunction. Am J Cardiol 57: 563–570PubMedCrossRefGoogle Scholar
  13. 13.
    McLaran CJ, Gersh Bi, Sugrue DD, Hammill SC, Seward JB, Holmes DR Jr (1985) Tachycardia induced myocardial dysfunction: a reversible phenomenon? Br Heart J 53: 323–327PubMedCrossRefGoogle Scholar
  14. 14.
    Leather RA, Kerr CR (1992) Atrial fibrillation in the absence of overt cardiac disease. In: Falk RH, Podrid PJ (eds) Atrial fibrillation: mechanisms and management. Raven, New York, pp 93–108Google Scholar
  15. 15.
    Grogan M, Smith HC, Gersh BJ, Wood DL (1992) Left ventricular dysfunction due to atrial fibrillation in patients initially believed to have idiopathic dilated cardiomyopathy. Am J Cardiol 69: 1570–1573PubMedCrossRefGoogle Scholar
  16. 16.
    Selzer A (1960) Effects of atrial fibrillation upon the circulation in patients with mitral stenosis. Am Heart J 59: 518–526PubMedCrossRefGoogle Scholar
  17. 17.
    Graettinger JS, Carleton RA, Muenster JJ (1964) Circulatory consequences of changes in cardiac rhythm produced in patients by transthoracic direct-current shock. J Clin Invest 43: 2290–2295PubMedCrossRefGoogle Scholar
  18. 18.
    Morris JJ, Entman M, North WC et al (1965) The changes in cardiac output with reversion of atrial fibrillation to sinus rhythm. Circulation 31: 670–678PubMedGoogle Scholar
  19. 19.
    Reale A (1965) Acute effects of countershock conversion of atrial fibrillation upon right and left heart hemodynamics. Circulation 32: 214–222PubMedGoogle Scholar
  20. 20.
    Killip T, Baer R (1965) Hemodynamic effect after reversion from atrial fibrillation to sinus rhythm by precordial shock. J Clin Invest 45: 658–670CrossRefGoogle Scholar
  21. 21.
    Shapiro W, Klein G (1968) Alterations in cardiac function immediately following electrical conversion of atrial fibrillation to normal sinus rhythm. Circulation 38: 1074–1078PubMedGoogle Scholar
  22. 22.
    Glancy DL, O’Brein KP, Gold HK et al (1970) Atrial fibrillation in patients with idiopatic hypertrophie subaortic stenosis. Am Heart J 32: 652–658Google Scholar
  23. 23.
    Di Pede F, Raviele A, Zuin G et al (1987) Quando, come e perché riconverire a ritmo una fibrillazione atriale. In: Raviele A, Alboni P (eds) Third International Workshop on Cardiac Arrythmias, Venice, 21–23 October 1993. 11 Pensiero Scientifico Editore, Rome, pp 55–62Google Scholar
  24. 24.
    Piccolo E, Delise P, Alboni P et al (1991) Problemi elettrofisiologici e clinici della fibrillazione atriale. G Ital Cardiol 21: 437–459Google Scholar
  25. 25.
    Scarfò S, Papparella N, Fucà G, Yannacopulu P, Alboni P (1993) Perché conquistare a tutti i costi it ritmo sinusale? Quale vantaggio emodinamico per it paziente? G Hal Cardiol 23 [Sup-pl I]: 98–102Google Scholar
  26. 26.
    Atwood JE, Myers J, Sullivan M et al (1988) Maximal exercise testing and gas exchange in patients with chronic atrial fibrillation. J Am Coll Cardiol 11: 508–513PubMedCrossRefGoogle Scholar
  27. 27.
    Manning W, Leeman DE, Gotch PJ, Come PC (1989) Pulsed Doppler evaluation of atrial mechanical function after electrical cardioversion of atrial fibrillation. J Am Coll Cardiol 13: 617–623PubMedCrossRefGoogle Scholar
  28. 28.
    Pollick C (1992) Echocardiography in atrial fibrillation. In: Falk RH, Podrid PJ (eds) Atrial fibrillation: mechamisms and management. Raven, New York, pp 165–180Google Scholar
  29. 29.
    Sanfilippo AJ, Abascal VM, Sheehan M et al (1990) Atrial enlargement has a consecuence of atrial fibrillation. A prospective echocardiographic study. Circulation 82: 791–797CrossRefGoogle Scholar
  30. 30.
    Van Gelder IC, Crijns HJ, Van Gilst WH, Hamer HPM, Lie KI (1991) Decrease of right and left atrial size after direct current electrical cardioversion in chronic atrial fibrillation. Am J Cardiol 67: 93–95PubMedCrossRefGoogle Scholar
  31. 31.
    Hinton RC, Kistler JP, Fallon JT, Friedlich AL, Fisher CM (1977) Influence of etiology of atrial fibrillation on incidence of systemic embolism. Am J Cardiol 40: 509–513PubMedCrossRefGoogle Scholar
  32. 32.
    Wolf PA, Dawber TR, Thomas HE, Kannel WB (1978) Epidemiologic assessment of chronic atrial fibrillation and risk of stroke: the Framingham study. Neurology 28: 973–977PubMedGoogle Scholar
  33. 33.
    Albers GW, Atwood JE, Hirsh J, Sherman DG, Hughes RA, Connolly SJ (1991) Stroke prevention in nonvalvular atrial fibrillation. Ann Intern Med 115: 727–736PubMedGoogle Scholar
  34. 34.
    Wolf PA, Abbott RD, Kannel WB (1987) Atrial fibrillation: major contributor to stroke in the elderly. Arch Intern Med 147: 1561–1564PubMedCrossRefGoogle Scholar
  35. 35.
    Stroke Prevention in Atrial Fibrillation Study Group Investigators (1990) Preliminary report of the Stroke Prevention in Atrial Fibrillation Study. N Engl J Med 322: 863–868Google Scholar
  36. 36.
    Fisher CM (1979) Reducing risk of cerebral embolism. Geriatrics 34: 59–66PubMedGoogle Scholar
  37. 37.
    Stroke Prevention in Atrial Fibrillation Investigators (1992) Predictors of thromboembolism in atrial fibrillation. I. Clinical features of patients at risk. Ann Intern Med 116: 1–5Google Scholar
  38. 38.
    Flegel KM, Hanley J (1989) Risk factors for stroke and other embolic events in patients with nonrheumatic atrial fibrillation. Stroke 20: 1000–1004PubMedCrossRefGoogle Scholar
  39. 39.
    Cairns JA, Connolly SJ (1991) Nonrheumatic atrial fibrillation: risk of stroke and role of antithrombotic theraphy. Circulation 84: 469–481PubMedGoogle Scholar
  40. 40.
    Kannel WB, Abbott RD, Savage DD, McNamara PM (1982) Epidemiologic features of chronic atrial fibrillation: the Framingham study. N Engl J Med 306: 1018–1022PubMedCrossRefGoogle Scholar
  41. 41.
    Onundarson PT, Thorgeirsson G, Jonmundsson E, Sigfusson N, Hardson T (1987) Chronic atrial fibrillation — epidemiologic features and 14 year follow-up: a case control study. Eur Heart J 3: 521–527Google Scholar
  42. 42.
    Kitchin AH, Milne JS (1977) Longitudinal survey of ischaemic heart disease in randomly selected sample of older population. Br Heart J 39: 889–893PubMedCrossRefGoogle Scholar
  43. 43.
    Petersen P, Boysen G, Godtfredsen J, Andersen E, Andersen B (1989) Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation. Lancet 1: 175–178PubMedCrossRefGoogle Scholar
  44. 44.
    The Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators (1990) The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation. N Engl J Med 323: 1505–1511CrossRefGoogle Scholar
  45. 45.
    Stroke Prevention in Atrial Fibrillation Investigators (1991) Stroke prevention in atrial fibrillation study. Final results. Circulation 84: 527–539Google Scholar
  46. 46.
    Evans W, Swann P (1954) Lone auricular fibrillation. Br Heart J 16: 189–194PubMedCrossRefGoogle Scholar
  47. 47.
    Kopecky SL, Gersh BJ, McGoon MD, Whisnant JP, Holmes DR, Ilstrup DM, Frye RL (1987) The natural history of lone atrial fibrillation. N Engl J Med 317: 669–674PubMedCrossRefGoogle Scholar
  48. 48.
    Gajewski J, Singer RB (1981) Mortality in an insured population with atrial fibrillation. JAMA 245: 1540–1544PubMedCrossRefGoogle Scholar
  49. 49.
    Carson PE, Johnson GR, Dunkman WB, Fletcher RD, Farrell L, Cohn JN (1993) The influence of atrial fibrillation on prognosis in mild to moderate heart failure. Circulation 87 [Suppl VI]: 102–110Google Scholar
  50. 50.
    Middlekauff HR, Stevenson WG, Stevenson LW (1991) Prognostic significance of atrial fibrillation in advanced heart failure. A study of 390 patients. Circulation 84: 40–48PubMedGoogle Scholar
  51. 51.
    Keogh AM, Baron DW, Hickie JB (1990) Prognostic guides in patients with idiopathic or ischemic dilated cardiomyopathy assessed for cardiac transplantation. Am J Cardiol 65: 903–908PubMedCrossRefGoogle Scholar
  52. 52.
    Unverferth DV, Magorien RD, Moescberger ML, Baker PB, Fetters JK, Leier CV (1984) Factors influencing the one-year mortality of dilated cardiomyopathy. Am J Cardiol 54: 147–152PubMedCrossRefGoogle Scholar
  53. 53.
    Cameron A, Schwartz MJ, Kronmal RA, Kosinski AS (1988) Prevalence and significance of atrial fibrillation in coronary artery disease ( CASS Registry ). Am J Cardiol 61: 714–717Google Scholar
  54. 54.
    Kannel WB, Abbott RD, Savage DD, McNamara PM (1983) Coronary heart disease and atrial fibrillation: the Framingham study. Am Heart J 106: 389–396PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Italia, Milano 1996

Authors and Affiliations

  • F. Di Pede
    • 1
  • G. Zuin
    • 1
  1. 1.Divisione di CardiologiaOspedale Umberto IMestre-VeniceItaly

Personalised recommendations